Amarantus Bioscience Holdings Inc (AMBS)

[Skeetz99]

Here you go......

Per Gerald:

"The proceeds from this second closing will allow the Company to achieve additional milestones for its MANF and LymPro programs, including the development of collaborations with major research institutions currently conducting research on MANF, as well as complete additional clinical studies for LymPro as we move it towards commercialization," said Gerald E. Commissiong, President & CEO of Amarantus. "Most importantly, assuming the full exercise of the warrants in this financing if our common shares trade above $0.10, management believes the Company should meet the listing standards required to up-list to a national exchange without the need to raise additional capital. With the full exercise of the warrants, the Company will have sufficient capital to operate into 2015."